Will AbbVie, maker of the world’s best-selling drug, finally face the music over its price hikes?

Fortune

20 May 2021 - If you're looking for a story which encapsulates the duality of the pharmaceutical industry, you don't have to search much further than AbbVie. 

That tale may finally be reaching a turning point, if bipartisan grilling of the company's CEO Richard Gonzalez by Congressional leaders on Tuesday are any indication.

Read Fortune article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing